Skip to main content
OpenTrials
Completed

NCT Number: NCT05909475

Supplementation With GKEX Sports Probiotic Combo for Muscle Gain and Fat Loss Assessment

Objective: To discuss the "GKEX Sports Probiotics Combination (hereinafter referred to as GKEX)", a product commissioned by Grape King Biotechnology Co., Ltd., and its effects on increasing muscle mass, muscle strength, physical performance and improving body composition when combined with resistance exercise training. Method: The experiment adopts a double-blind design. After screening, 52 subjects (20 males and 32 females) were randomly divided into two groups, each with 10 males and 16 females: (1) placebo without GKEX probiotics Capsule group (Placebo) (2 capsules/day), (2) GKEX group (GKEX) (1x1010 CFU/capsule, 2 capsules/day). All subjects received daily supplementation samples for 6 weeks and received resistance exercise training three times a week. Before the intervention and 6 weeks after the intervention, the diet evaluation, systemic and resistive body composition, muscle ultrasound, muscle strength, maximum oxygen uptake, explosive power, anaerobic power, etc. were detected respectively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Graduate Institute of Sports Science, National Taiwan Sport University

Taoyuan, 33301, Taiwan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The tissues and organs of the body are functioning normally
  • no disease, fatigue, or weakness
  • independent and flexible activities

Exclusion criteria

  • With a history of cardiovascular disease, hypertension, metabolic disease, asthma or cancer diagnosed by a physician
  • BMI≧27
  • Who have taken anti-inflammatory analgesics or acute and chronic diseases within one month, etc.,
  • The students and related stakeholders guided by the host of this plan
  • Who have the habit of smoking and drinking
  • Within two weeks Have used probiotic products in powder, capsule or tablet form (including yogurt, yogurt, Yakult and other related foods)
  • Food or allergic to lactic acid bacteria products
  • Have had hepatobiliary and gastrointestinal surgery within 2 years (except hernia and polypectomy)

Treatment and study plan

GKEX

Dietary Supplement

GKEX group. Probiotic capsules contain 10 billion CFU (colony forming units) of GKEX, , 2 caps daily use.

Placebo

Other

The placebo capsule contains microcrystalline cellulose, 2 caps daily use.

Primary outcomes

  1. Isometric Mid-Thigh Pull (IMTP_RFD

    Time frame: up to 6 weeks

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded.

  2. Isometric Mid-Thigh Pull (IMTP)_relative peak force

    Time frame: up to 6 weeks

    Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded.

  3. Wingate Anaerobic Test (WAnT)_relative peak power

    Time frame: up to 6 weeks

    After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The average relative peak power parameters were recorded.

  4. Wingate Anaerobic Test (WAnT)_relative mean power

    Time frame: up to 6 weeks

    After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The average relative mean power parameters were recorded.

  5. Wingate Anaerobic Test (WAnT)_fatigue index

    Time frame: up to 6 weeks

    After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The average fatigue index parameters were recorded.

  6. The Countermovement Jump (CMJ) Test

    Time frame: up to 6 weeks

    The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The average power (MF), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight.

  7. VO2max

    Time frame: up to 6 weeks

    To evaluate the maximum oxygen consumption and exercise performance, we used a treadmill (Pulsar, h/p/cosmos, Nussdorf-Traunstein, Germany) and an automatic breathing analyzer (Vmax 29c, Sensor Medics, Yorba Linda, CA, USA). In addition, a polar heart rate device was used to monitor the heart rate (HR). The speed range of the treadmill was set to 7.2 km/h and increased by 1.8 km/h every 2 min until fatigue, according to Bruce's protocol. When the breathing exchange rate (the volume ratio of carbon dioxide produced to oxygen consumed, VCO2/VO2) was higher than 1.10 and reached the maximum heart rate (maximum heart rate = 220 - age), oxygen consumption was considered to be maximum. The three highest VO2max peak were averaged to obtain the VO2max values of the individual volunteers.

  8. Muscle composition_muscle thickness

    Time frame: up to 6 weeks

    Use muscular ultrasound (BenQ T3300) to scan muscle thickness

  9. Muscle composition_fascia thickness

    Time frame: up to 6 weeks

    Use muscular ultrasound (BenQ T3300) to scan fascia thickness

  10. dual-energy X-ray absorptiometry, DXA

    Time frame: up to 6 weeks

    A non-invasive dual-energy X-ray absorptive bone density testing room (Lunar iDXA, GE Healthcare, Chicago, IL, USA) was used for systemic body composition and bone density measurements. The subject was required to lie flat on the test bed, with their body at the center line, and their limbs within the detection range. Two different energy X-rays were used to scan the inspected part, then the scintillation detector received the X-rays that had penetrated the inspected part, and analyzed the obtained muscle mass

  11. Body composition_body fat

    Time frame: up to 6 weeks

    The multi-frequency principle was applied to measure body composition by using a bioelectrical impedance analyzer (BIA) on an InBody 570 device (In-body, Seoul, South Korea). To perform the measurements, after the subjects' palms and soles were removed from the sensors, the subjects stood on the footing electrodes and held the sensing handles with two hands. During the measurements, the subjects kept their arms open and left their bodies at an angle of 30° without speaking or moving. The subjects also fasted for at least 8 h before the test. The body fat were meansure

  12. Body composition_muscle mass

    Time frame: up to 6 weeks

    The multi-frequency principle was applied to measure body composition by using a bioelectrical impedance analyzer (BIA) on an InBody 570 device (In-body, Seoul, South Korea). To perform the measurements, after the subjects' palms and soles were removed from the sensors, the subjects stood on the footing electrodes and held the sensing handles with two hands. During the measurements, the subjects kept their arms open and left their bodies at an angle of 30° without speaking or moving. The subjects also fasted for at least 8 h before the test. The muscle mass were meansure

  13. Grip strength

    Time frame: up to 6 weeks

    Use the armed grip machine (T.K.K.5401, Takei Scientific Instruments Co.,Ltd, Niigata, Japan) to measure, hold each of the left and right hands three times until they are weak, and record the maximum value

Secondary outcomes

  1. Safety assessment - AST

    Time frame: up to 6 weeks

    Safety is assessed function of liver such as AST (8-38 IU/L).

  2. Safety assessment - ALT

    Time frame: up to 6 weeks

    Safety is assessed function of liver such as ALT (4-44 IU/L).

  3. Safety assessment - T-Cholesterol

    Time frame: up to 6 weeks

    Safety is assessed function of blood lipid such as T-Cholesterol (<200 mg/dL).

  4. Safety assessment - Uric Acid

    Time frame: up to 6 weeks

    Safety is assessed function of kidney such as Uric Acid (3.4-7.6 mg/dl)

  5. Safety assessment - BUN

    Time frame: up to 6 weeks

    Safety is assessed function of kidney such as Bun (6-20 mg/dl)

  6. Safety assessment - Creatinine

    Time frame: up to 6 weeks

    Safety is assessed function of kidney such as Creatinine (0.6-1.3 mg/dl)

  7. Safety assessment - Glucose

    Time frame: up to 6 weeks

    Safety is assessed function of Glucose (70~100 mg/dL)

  8. Safety assessment - Triglycerides

    Time frame: up to 6 weeks

    Safety is assessed function of blood lipid such as Triglycerides (<150 mg/dL)

  9. Safety assessment - LDL

    Time frame: up to 6 weeks

    Safety is assessed function of blood lipid such as LDL (0~140mg/dl)

  10. Safety assessment - HDL

    Time frame: up to 6 weeks

    Safety is assessed function of blood lipid such as HDL (>40mg/dl)

Sponsors and collaborators

Lead sponsor

National Taiwan Sport University

Other

Collaborators

  • Grape King Bio Ltd.

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jun 18, 2023
Registry last updated
Jun 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.